Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents

NMR in Biomedicine

Volumn 26, Issue 7, 2013, Pages 781-787

  Tu, Chuqiao ^a   Louie, Angelique Y ^a  

^a University of California Davis   (United States)

Author keywords

Gadolinium; in vivo imaging; Luciferase; NADH; Redox; Reversible switching; Smart contrast agent; Spiropyran

Indexed keywords

CONTRAST AGENT; IN-VIVO IMAGING; LUCIFERASE; NADH; REDOX; REVERSIBLE SWITCHING; SPIROPYRANS;

GADOLINIUM; MAGNETIC RESONANCE IMAGING; METAL IONS; PHYSIOLOGICAL MODELS; PHYSIOLOGY;

MOLECULAR IMAGING;

GADOLINIUM; METAL ION; NAPHTHOXAZINE DERIVATIVE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PYRAN DERIVATIVE; TETRAXETAN;

ARTICLE; CHEMICAL MODIFICATION; COMPLEX FORMATION; DRUG DESIGN; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; GAMMA RADIATION; HYDRATION; ISOMERIZATION; LIGHT ABSORPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

CONTRAST MEDIA; GADOLINIUM; HUMANS; HYDROGEN-ION CONCENTRATION; LIGHT; MAGNETIC RESONANCE IMAGING; OXIDATION-REDUCTION;

EID: 84879533953     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2870     Document Type: Article

References (41)

1. Tu CQ, Osborne EA, Louie AY. Activatable T(1) and T(2) magnetic resonance imaging contrast agents. Ann. Biomed. Eng. 2011; 39(4): 1335-1348.
2. Toth E, Helm L, Merbach AE. Relaxivity of MRI contrast agents. Contrast Agents I 2002; 221: 61-101.
3. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 2006; 35(6): 512-523.
4. Burtea C, Laurent S, Elst LV, Muller RN. Contrast agents: magnetic resonance. In: Semmler W, Schwaiger M (eds). Molecular Imaging I: Handbook of Experimental Pharmacology. Springer-Verlag: Berlin; 2008, pp. 135-165.
5. Querol M, Bogdanov A. Environment-sensitive and enzyme-sensitive MR contrast agents. In: Semmler W, Schwaiger M (eds). Molecular Imaging II. Handbook of Experimental Pharmacology. Springer-Verlag: Berlin; 2008, pp. 37-57.
6. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang SR, Gillies RJ. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn. Reson. Med. 2006; 55(2): 309-315.
7. Zhang SR, Wu KC, Sherry AD. A novel pH-sensitive MRI contrast agent. Angew. Chem. Int. Ed. 1999; 38(21): 3192-3194.
8. Badr CE, Tannous BA. Bioluminescence imaging: progress and applications. Trends Biotechnol. 2011; 29(12): 624-633.
9. Zhi JF, Baba R, Hashimoto K, Fujishima A. Photoelectrochromic properties of a spirobenzopyran derivative. J. Photochem. Photobiol. A: Chem. 1995; 92(1-2): 91-97.
10. Berkovic G, Krongauz V, Weiss V. Spiropyrans and spirooxazines for memories and switches. Chem. Rev. 2000; 100(5): 1741-1753.
11. Wojtyk JTC, Kazmaier PM, Buncel E. Effects of metal ion complexation on the spiropyran-merocyanine interconversion: development of a thermally stable photo-switch. Chem. Commun. 1998; 16: 1703-1704.
12. Chibisov AK, Gorner H. Complexes of spiropyran-derived merocyanines with metal ions: relaxation kinetics, photochemistry and solvent effects. Chem. Phys. 1998; 237(3): 425-442.
13. Gorner H, Chibisov AK. Complexes of spiropyran-derived merocyanines with metal ions - thermally activated and light-induced processes. J. Chem. Soc. Faraday Trans. 1998; 94(17): 2557-2564.
14. Tu CQ, Louie AY. Photochromically-controlled, reversibly-activated MRI and optical contrast agent. Chem. Commun. 2007; 13: 1331-1333.
15. Tu CQ, Osborne EA, Louie AY. Synthesis and characterization of a redox- and light-sensitive MRI contrast agent. Tetrahedron 2009; 65(7): 1241-1246.
16. Tu C, Nagao R, Louie AY. Multimodal magnetic-resonance/optical-imaging contrast agent sensitive to NADH. Angew. Chem. Int. Ed. 2009; 48(35): 6547-6551.
17. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 1999; 99(9): 2293-2352.
18. Aime S, Botta M, Bruce JI, Mainero V, Parker D, Terreno E. Modulation of the water exchange rates in Gd-DO3A complex by formation of ternary complexes with carboxylate ligands. Chem. Commun. 2001; 1: 115-116.
19. Djanashvili K, Peters JA. How to determine the number of inner-sphere water molecules in lanthanide(III) complexes by O-17 NMR spectroscopy. A technical note. Contrast Media Mol. Imaging 2007; 2(2): 67-71.
20. Perez-Mayoral E, Negri V, Soler-Padros J, Cerdan S, Ballesteros P. Chemistry of paramagnetic and diamagnetic contrast agents for magnetic resonance imaging and spectroscopy: pH responsive contrast agents. Eur. J. Radiol. 2008; 67(3): 453-458.
21. Lowe MP, Parker D, Reany O, Aime S, Botta M, Castellano G, Gianolio E, Pagliarin R. pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J. Am. Chem. Soc. 2001; 123(31): 7601-7609.
22. Gianolio E, Maciocco L, Imperio D, Giovenzana GB, Simonelli F, Abbas K, Bisi G, Aime S. Dual MRI-SPECT agent for pH-mapping. Chem. Commun. 2011; 47(5): 1539-1541.
23. Bonnet CS, Toth E. MRI probes for sensing biologically relevant metal ions. Future Med. Chem. 2010; 2(3): 367-384.
24. Que EL, Chang CJ. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem. Soc. Rev. 2010; 39(1): 51-60.
25. Li W-H, Fraser SE, Meade TJ. A calcium-sensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 1999; 121(6): 1413-1414.
26. 3+ complexes. J. Biol. Inorg. Chem. 2008; 13(1): 35-46.
27. 3+ complexes: an attempt towards calcium-sensitive MRI contrast agents. Inorg. Chem. 2008; 47(4): 1370-1381.
28. Angelovski G, Fouskova P, Mamedov I, Canals S, Toth E, Logothetis NK. Smart magnetic resonance imaging agents that sense extracellular calcium fluctuations. Chembiochem 2008; 9(11): 1729-1734.
29. Mishra A, Logothetis NK, Parker D. Critical In vitro evaluation of responsive MRI contrast agents for calcium and zinc. Chem. Eur. J. 2011; 17(5): 1529-1537.
30. Kubíček V, Vitha T, Kotek J, Hermann P, Vander Elst L, Muller RN, Lukeš I, Peters JA. Towards MRI contrast agents responsive to Ca(II) and Mg(II) ions: metal-induced oligomerization of dota-bisphosphonate conjugates. Contrast Media Mol. Imaging 2010; 5(5): 294-296.
31. Mamedov I, Logothetis NK, Angelovski G. Structure-related variable responses of calcium sensitive MRI probes. Org. Biomol. Chem. 2011; 9(16): 5816-5824.
32. Que EL, Chang CJ. A smart magnetic resonance contrast agent for selective copper sensing. J. Am. Chem. Soc. 2006; 128(50): 15 942-15 943.
33. Que EL, Gianolio E, Baker SL, Wong AP, Aime S, Chang CJ. Copper-responsive magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2009; 131(24): 8527-8536.
34. Que EL, Gianolio E, Baker SL, Aime S, Chang CJ. A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility. Dalton Trans. 2010; 39(2): 469-476.
35. Li WS, Luo JA, Chen ZN. A gadolinium(III) complex with 8-amidequinoline based ligand as copper(II) ion responsive contrast agent. Dalton Trans. 2011; 40(2): 484-488.
36. Kasala D, Lin TS, Chen CY, Liu GC, Kao CL, Cheng TL, Wang YM. Gd(Try-TTDA)(H(2)O) (2-): a new MRI contrast agent for copper ion sensing. Dalton Trans. 2011; 40(18): 5018-5025.
37. Aime S, Fedeli F, Sanino A, Terreno E. A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent. J. Am. Chem. Soc. 2006; 128(35): 11 326-11 327.
38. Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA. Quantitative " magnetic resonance immunohistochemistry "with ligand-targeted F-19 nanoparticles. Magn. Reson. Med. 2004; 52(6): 1255-1262.
39. Louie A. Multimodality imaging probes: design and challenges. Chem. Rev. 2010; 110(5): 3146-3195.
40. Frullano L, Catana C, Benner T, Sherry AD, Caravan P. Bimodal MR-PET agent for quantitative pH imaging. Angew. Chem. Int. Ed. 2010; 49(13): 2382-2384.
41. Tu CQ, Louie AY. Nanoformulations for molecular MRI. WIREs. Nanomed. Nanobiotechnol 2012; 4(4): 448-457.